Important pharmacy news and late-breaking industry information updated daily.

Study sheds light on measures that could reduce misuse

Congress on Tuesday gave final approval to legislation that would allow patients with serious illnesses to try unproven experimental treatments, sending the measure to President Trump for his expected signature into law. The House passed the same "right-to-try" bill that was approved in August by unanimous consent in the Senate.

Patients in the clinic had a 3.2-point decrease in A1C at 6 months

FDA approved on Monday avatrombopag (Doptelet—AkaRx) tablets for the treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.

JAPhA study: Millions of additional vaccinations are given each year because of ready access at pharmacies

Many ALS patients cannot afford the $145,000 price of the drug edavarone (Radicava—Mitsubishi Tanabe) without insurance, but some insurance provider have denied access to the drug, even though it was approved by FDA last fall for treatment of the disease.

Aim is to improve safe and effective medications to patients worldwide

FDA approved on Wednesday lofexidine hydrochloride (Lucemyra—US WorldMeds) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

While the annual conference focuses on opioid abuse, more programming on appropriate pain management was included this year

FDA has approved epoetin alfa-epbx (Retacrit—Hospira) as a biosimilar to epoetin alfa (Epogen/Procrit—Amgen) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine for individuals with HIV.